UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jul 28, 2026
Sale
Calculated transaction value
$775.29K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jul 28, 2026
Public filing date
Jul 28, 2026
Filing lag
Filed same day
UTHR daily price context
Close on/before transaction
$523.63
Jul 28, 2026
Close before public filing
$527.94
Jul 27, 2026
Return since public filing
-5.84%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,473 shares @ $526.34
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000108
Filing cohort
Transactions in this filing
Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$6.29M
Buys / sales
0 / 10
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Jul 28, 2026 | $721.68K |
| United Therapeutics Corp UTHR | Exercise | Jul 28, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Jul 28, 2026 | $330.88K |
| United Therapeutics Corp UTHR | Sale | Jul 28, 2026 | $715.15K |
| United Therapeutics Corp UTHR | Exercise | Jul 28, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Jul 28, 2026 | $21.3K |
| United Therapeutics Corp UTHR | Sale | Jul 28, 2026 | $606.9K |
| United Therapeutics Corp UTHR | Sale | Jul 28, 2026 | $459.92K |
| United Therapeutics Corp UTHR | Sale | Jul 28, 2026 | $596.05K |
| United Therapeutics Corp UTHR | Sale | Jul 28, 2026 | $213.98K |
| United Therapeutics Corp UTHR Current | Sale | Jul 28, 2026 | $775.29K |
| United Therapeutics Corp UTHR | Sale | Jul 28, 2026 | $562.82K |